2002
DOI: 10.1074/jbc.m209281200
|View full text |Cite
|
Sign up to set email alerts
|

Identification of the Bovine γ-Aminobutyric Acid Type A Receptor α Subunit Residues Photolabeled by the Imidazobenzodiazepine [3H]Ro15-4513

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
45
0
3

Year Published

2003
2003
2017
2017

Publication Types

Select...
6
3
1

Relationship

2
8

Authors

Journals

citations
Cited by 53 publications
(50 citation statements)
references
References 48 publications
1
45
0
3
Order By: Relevance
“…Photoaffinity labeling has successfully been used to locate the benzodiazepine (Davies et al, 1996;Duncalfe et al, 1996;Sawyer et al, 2002;Wieland et al, 1992) and muscimol (Smith & Olsen, 1994) binding sites on the GABA A receptor, and sites for etomidate (Husain et al, 2006;Ziebell et al, 2004) and octanol (Pratt et al, 2000) on the Torpedo nicotinic acetylcholine receptor. In principle photoaffinity labeling techniques should provide a comprehensive search of all possible protein targets and should not be confounded by either multiple regions of protein contributing to a binding site or by the existence of multiple binding sites.…”
Section: E Insights From Photoaffinity Labelsmentioning
confidence: 99%
“…Photoaffinity labeling has successfully been used to locate the benzodiazepine (Davies et al, 1996;Duncalfe et al, 1996;Sawyer et al, 2002;Wieland et al, 1992) and muscimol (Smith & Olsen, 1994) binding sites on the GABA A receptor, and sites for etomidate (Husain et al, 2006;Ziebell et al, 2004) and octanol (Pratt et al, 2000) on the Torpedo nicotinic acetylcholine receptor. In principle photoaffinity labeling techniques should provide a comprehensive search of all possible protein targets and should not be confounded by either multiple regions of protein contributing to a binding site or by the existence of multiple binding sites.…”
Section: E Insights From Photoaffinity Labelsmentioning
confidence: 99%
“…Photoaffinity labeling, which provides an experimental approach to directly identify amino acids contributing to a drug binding site without previous assumptions about the protein points of contact (Kotzyba-Hibert et al, 1995), has been used extensively to identify amino acids contributing to ligand binding sites in the Torpedo nAChR (Mourot et al, 2006) and for GABA A R agonists and benzodiazepines (Smith and Olsen, 1994;Duncalfe et al, 1996;Sawyer et al, 2002). We now use 2-(3-methyl-3H-diaziren-3-yl) ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate ([ 3 H]azietomidate), a photoreactive analog of etomidate that retains anesthetic and GABA A R modulatory properties (Husain et al, 2003), to provide the first identification of amino acids contributing to an anesthetic binding site in a GABA A R. The two labeled residues, ␣M1-14 (␣Met-236) and , are shown by homology modeling to border a pocket in the TMD located at the same subunit interfaces that contain the GABA binding site in the extracellular domain.…”
Section: Introductionmentioning
confidence: 99%
“…Mutagenesis studies identified the cleft between a and c subunits as the binding pocket for benzodiazepines [12][13][14]. a 1 H101 was identified as the target of photoaffinity labeling by [ 3 H] flunitrazepam [15] and a 1 Y209 as the target of [ 3 H] Ro15-4513 [16]. Pharmacophore modeling attempted to describe the shape of the binding pocket [17,18].…”
Section: Introductionmentioning
confidence: 99%